Showing results (251-260 of 673) with videos related to

Sort By:
Pageof 68
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Progesterone receptor determined by immunocytochemical and biochemical methods in human breast cancerG Gasparini, F Pozza, R Dittadi, et al.
American Journal of Clinical Oncology|February 1, 1991
Weekly epirubicin versus doxorubicin as second line therapy in advanced breast cancer. A randomized clinical trialG Gasparini, S Dal Fior, G A Panizzoni, et al.
International Orthopaedics|March 8, 2006
Local infusion of norepinephrine reduces blood losses and need of transfusion in total knee arthroplastyG Gasparini, P Papaleo, P Pola, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|March 4, 2015
Vasculitis associated with connective tissue diseasesE Cozzani, G Gasparini, M Papini, et al.
Minerva Chirurgica|October 22, 1998
[Jejunal diverticulosis. Presentation of a clinical case]R Accordino, A Zangrandi, E Inzani, et al.
Minerva Chirurgica|May 25, 2002
Evaluation of homologous bone graft versus biomaterials in the aesthetic restoration of the middle third of the faceA Carboni, G Gasparini, M Perugini, et al.
Tumori|February 24, 2001
Clinical management of a case of recurrent apocrine gland carcinoma of the scalp: efficacy of a chemotherapy schedule with methotrexate and bleomycinA Morabito, P Bevilacqua, S Vitale, et al.
Anticancer Research|November 1, 1991
Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressivenessG Gasparini, F Pozza, S Meli, et al.
Anticancer Research|July 1, 1991
Relationship of the epidermal growth factor-receptor to the growth fraction (Ki-67 antibody) and the flow cytometric S-phase as cell kinetics parameters, in human mammary carcinomasG Gasparini, M Reitano, P Bevilacqua, et al.
Clinical Orthopaedics and Related Research|January 1, 1991
Radiation therapy to prevent heterotopic ossification after cementless total hip arthroplastyW F Kennedy, T A Gruen, H Chessin, et al.
Pageof 68